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Abstract 21 
Stable isotope labelling by amino acids in cell culture (SILAC) in conjunction with mass 22 
spectrometry analysis is a sensitive and reliable technique for quantifying relative differences in 23 
protein abundance and post-translational modifications between cell populations. We have 24 
developed and utilised SILAC-MS workflows for quantitative proteomics in the fungal pathogen 25 
Candida albicans. Arginine metabolism provides important cues for escaping host defences during 26 
pathogenesis, which limits the use of auxotrophs in Candida research. Our strategy eliminates the 27 
need for engineering arginine auxotrophs for SILAC experiments and allows the use of ARG4 as 28 
selectable marker during strain construction. Cells that were auxotrophic for lysine were 29 
successfully labelled with both lysine and arginine stable isotopes. We found that prototrophic C. 30 
albicans preferentially uses exogenous arginine and downregulates internal production, which 31 
allowed it to achieve high incorporation rates. However, similar to other yeast, C. albicans was 32 
able to metabolise heavy arginine to heavy proline, which compromised the accuracy of protein 33 
quantification. A computational method was developed to correct for the incorporation of heavy 34 
proline. In addition, we utilised the developed SILAC labelling in Candida albicans for the global 35 
quantitative proteomic analysis of a strain expressing a phosphatase-dead mutant Cdc14PD.  36 
 37 
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 40 
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Significance of the study 44 
The fungus Candida albicans is commonly found on the skin and mucosal surfaces of healthy 45 
people, but in susceptible individuals, it causes infections ranging from superficial to life 46 
threatening. In this study we have developed and utilised SILAC-MS workflows for 47 
quantitative proteomics in the fungal pathogen Candida albicans. In C. albicans, arginine is 48 
commonly used as a selectable marker in strain engineering. Arginine metabolism provides 49 
important cues for escaping host defences during pathogenesis, which limits the use of 50 
auxotrophs in Candida research. In this study we have utilised a strategy that eliminates the 51 
need for engineering arginine auxotrophs for SILAC experiments and allows the use of ARG4 52 
as selectable marker during strain construction in Candida albicans. We believe the 53 
application of nSILAC in Candida offers a powerful tool for quantitative proteomic studies in 54 
the fungal pathogen Candida albicans. This opens up new possibilities for studying protein 55 
interactions, post-translational modifications and whole proteome changes in response to 56 
different factors that occur during the lifecycle of this fungus. 57 
 58 
 59 
 60 
 61 
 62 
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Introduction 65 
Stable isotope labelling by amino acids in cell culture (SILAC) is a metabolic labelling technique that 66 
has been widely used for accurate quantitative mass spectrometry (MS) studies [1, 2]. In principle, 67 
two cell populations are grown in the presence of either light (naturally occurring) or heavy isotope 68 
enriched amino acids, such as lysine and arginine, and incorporate them into their proteomes. Cells 69 
from both cultures are harvested and mixed together, so that downstream sample processing does 70 
not introduce quantitative errors. Subsequent MS analysis of the peptide digests facilitates global 71 
protein characterization and quantification ?dŚĞ ůŝŐŚƚĂŶĚŚĞĂǀǇƉĞƉƚŝĚĞƐĨŽƌŵ “^/>ƉĂŝƌƐ ?in the 72 
survey spectrum due to the mass difference of the isotopes. The labels allow the origin of peptides 73 
to be traced back to the starting culture and thus SILAC is used to detect relative differences in 74 
protein abundance or post-translational modifications between samples. The isotopes have no 75 
effect on cell metabolism, so any differences found by SILAC-MS can be attributed to the 76 
experimental conditions or genetic make-up of the cells. 77 
 In SILAC experiments, it is imperative that cells use the exogenous amino acids present in 78 
the media and do not synthesise them on their own. For this reason, studies have typically employed 79 
auxotrophic mutants, where genes involved in lysine and/or arginine biosynthesis have been 80 
deleted. However, recently it has been demonstrated that the proteomes of prototrophic yeast and 81 
bacteria can also be metabolically labelled with heavy lysine [4]. In these organisms, the 82 
supplemental lysine in the media inhibited its own production and achieved similar incorporation 83 
rates to auxotrophic strains. Importantly, this was shown to occur only in exponentially growing 84 
cells. In stationary phase, cells resumed biosynthesis of lysine and the labelling efficiency steadily 85 
decreased [5]. Nevertheless, this approach known as native SILAC (nSILAC) is a valuable alternative 86 
to traditional SILAC methods, especially in investigations where generation of auxotrophic strains is 87 
not possible or not practical.  88 
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 The possibility of performing nSILAC with arginine prototrophs has not been explored yet. 89 
The use of heavy arginine for metabolic labelling has been more problematic because many 90 
organisms, including yeast, use it as a precursor for synthesis of other amino acids, mainly proline [6, 91 
7]. As a result, each proline-containing peptide from the heavy-labelled strain forms a cluster of 92 
monoisotopic peaks on the mass spectrum, with only the highest peak intensity used in quantitation. 93 
This reduces the intensity of the heavy peptides and skews the calculated peptide ratio towards the 94 
light version. To solve this issue, several strategies have been proposed to either correct peptide 95 
intensity post-quantitation, or prevent the conversion from happening in the first place. The rate of 96 
arginine-to-proline conversion may be modulated by carefully titrating the availability of both amino 97 
acids in the culture medium [8-11]. An excess of arginine and limited proline are likely to stimulate 98 
the conversion. On the other hand, shortage of arginine may lead to incomplete labelling, reduced 99 
growth rate and disruptions in metabolic processes. However, high concentrations of proline are not 100 
advised either, because it can also be converted to arginine and, again, compromise peptide 101 
quantitation. A more effective strategy has been described in Schizosaccharomyces pombe, where 102 
deletion of several arginase genes prevented the conversion of arginine to other amino acids [12, 103 
13]. In addition the use of 15N4-labelled arginine in the light medium and 13C615N4-labelled arginine in 104 
the heavy medium has also been used, allowing an internal correction to be applied at the 105 
quantitation step [14]. Lastly, several bioinformatic approaches have been developed to correct the 106 
intensity of proline-containing peptides [15-17]. 107 
Another issue related to the use of heavy arginine is that some species can metabolise it to 108 
different analogues. The most common version of heavy arginine used for metabolic labelling is 109 
Arg10. In fission yeast, Arg10 is converted not only to proline, but also to Arg7, resulting in additional 110 
ůŽǁĞƌŵŽůĞĐƵůĂƌǁĞŝŐŚƚ “ƉƌĞ-peĂŬƐ ?ŝŶƚŚĞŝƐŽƚŽƉŝĐĐůƵƐƚĞƌƐŽĨĂƌŐŝŶŝŶĞ-containing peptides [13]. This 111 
compromises the sensitivity of MS and significantly reduces the number of identified peptides, and 112 
limits peptide quantitation. 113 
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 The fungus Candida albicans is commonly found on the skin and mucosal surfaces of healthy 114 
people, but in susceptible individuals, it causes infections ranging from superficial to life threatening 115 
[18]. The transition from commensal to pathogenic state is a multifactorial event that is still not fully 116 
understood. Important strategies that allow C. albicans to adapt to a wide range of conditions 117 
include biofilm formation, morphogenetic plasticity and secretion of adhesins and hydrolases [19, 118 
20]. A better understanding of the molecular pathways governing these events is urgently needed in 119 
order to develop more effective treatments for C. albicans infections.  120 
Although metabolic labelling is ideally performed in conjunction with essential amino acids, 121 
this is not always possible. In C. albicans, arginine is commonly used as a selectable marker in strain 122 
engineering. Therefore, nSILAC in conjunction with arginine prototrophs would be a valuable 123 
alternative to traditional SILAC approaches. This is particularly relevant to studies investigating C. 124 
albicans host defence and morphological switching. Arginine biosynthesis is strongly upregulated in 125 
the early stages of cell phagocytosis by macrophages [21]. In this scenario, arginine is converted to 126 
urea, and the latter is degraded to CO2, which induces yeast-to-hypha transition and allows cells to 127 
escape the attack [22]. Arginine deficient strains cannot make the hyphal switch inside 128 
macrophages, and therefore prototrophs are required for studies investigating these processes.   129 
 In this study, we have developed and optimised SILAC labelling of C. albicans proteome for 130 
high throughput quantitative proteomics. We show that labelling with heavy arginine does not 131 
require the use of auxotrophic mutants, but necessitates additional correction of peptide 132 
quantitation in order to account for heavy proline conversion. Furthermore, as proof of principle, we 133 
have carried out the first global quantitative proteomic analysis using SILAC in C. albicans looking at 134 
proteome changes that occur in response to overexpressing an inactivated phosphatase Cdc14PD 135 
involved in cell separation, mitotic exit and morphogenesis.  136 
 137 
 138 
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Materials and methods 139 
Generation of strains  ? All strains were derived from the Candida albicans strain MDL04 140 
(ůǇƐ ? ? ?ŵ>h ? ?ůǇƐ ? ? ?Ě,/^ ? ĂƌŐ ?ȴ ?ĂƌŐ ?ȴ ůĞƵ ?ȴ ?ůĞƵ ?ȴ ŚŝƐ ȴ ?ŚŝƐ ?ȴ ƵƌĂ ?ȴ ? ?ŝŵŵ ? ? ? ?ƵƌĂ ?ȴ ? ?ŝŵŵ ? ? ?141 
ŝƌŽ ?ȴ ? ?ŝŵŵ ? ? ? ?ŝƌŽ ?ȴ ? ?ŝŵŵ ? ? ?), which was obtained from Carol Munro from The University of 142 
Aberdeen. CDC14 was fused to MYC-URA3 using a PCR cassette as previously described [23]. CDC14-143 
MYC was amplified from genomic DNA by PCR ƵƐŝŶŐ ƚŚĞ ƉƌŝŵĞƌƐ  ? ?-144 
GGCGGGCTCGAGGGCTTTCCTTTCCTTTGCTATG- ? ? ĂŶĚ  ? ?-145 
GGCGGGTCTAGACTAATTTGTGAGTTTAGTATACATGC- ? ? ĂŶĚ ĐůŽŶĞĚ ŝŶƚŽ ƉZ^ ? ƉůĂƐŵŝĚvia ligation 146 
with BamHI and XbaI and using the linker oligonucleotides GATCCCTCCCAGAAC and 147 
TCGAGTTCTGGGAGG. This resulted in plasmid pINK1 containing CDC14-MYC-URA3, in which the 148 
point mutation CDC14 ? ? ?^ ǁĂƐ ŝŶƐĞƌƚĞĚ ďǇ WZ ĂŵƉůŝĨŝĐĂƚŝŽŶ ƵƐŝŶŐ ƚŚĞ ƉƌŝŵĞƌƐ  ? ?-149 
GCAGTACATTCTAAAGCAGGGTTAGG- ? ? ĂŶĚ  ? ?-CCTAACCCTGCTTTAGAATGTACTGC- ? ? ?Cdc14C275S-150 
MYC-URA3 was excised and transformed into MDL04 as above. A regulatable promoter sequence 151 
ARG4-MET3 was fused to cdc14C275S as described by Gola, et al. ƵƐŝŶŐ ƚŚĞ ƉƌŝŵĞƌƐ  ? ?-152 
AAATGTATATAACGAAGATGACTATCATCAATGGTCCGGTTAGTAAAGCGAACAAGCTTTATAAAAATAGTTA153 
TGCTGAACGTACCATGAAGCTTCGTACGCTGCAGGTC- ? ? ĂŶĚ  ? ?-154 
AAAGGTAGAACAATCAATTTGAAGTAGATTTTCCCAACATACTTTTAAGAAACTCTATAAGAGGCACATGAAC155 
CAGTGAACTATGCATGTTTTCTGGGGAGGGTATTTAC- ? ?[24]. Successful transformation was confirmed 156 
by PCR, DNA sequencing and Western blot. In the article, this strain is written as Cdc14PD.  157 
SILAC media and growth conditions  ?MET3 promoter-repressing media containing: 6.7 g/L Difco 158 
yeast nitrogen base without amino acids, 20 g/L D-glucose, 670 mg/L Formedium ? complete 159 
supplement mixture drop-out: -arginine, -lysine, -methionine, 60.6 mg/L methionine, 373 mg/L 160 
cysteine and 80 mg/L uridine. MET3 promoter-inducing media contained the same ingredients, 161 
except no methionine and no cysteine were added. In addition, light medium contained 80 mg/L 162 
light arginine (Arg0: 12C6, 14N4) and 80 mg/L light lysine (Lys0: 12C6, 14N2), both supplied by Sigma 163 
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Aldrich. In addition, heavy medium contained 100 mg/L heavy arginine (Arg10: 13C6, 15N4) and 100 164 
mg/L heavy lysine (Lys8: 13C6, 15N2), both supplied by Cambridge Isotope Laboratories, Inc. Cells were 165 
routinely grown overnight at 30 °C, 200 rpm in 50 ml of either light or heavy MET3 promoter-166 
repressing media. In the morning, each culture was re-inoculated into 0.5 L light or heavy MET3 167 
promoter-inducing media at OD595=0.25 and cells were allowed to grow for approximately 4 hrs, at 168 
30 °C, 200 rpm until they reached OD595=0.7. At this point cells were harvested by centrifugation, 169 
frozen in liquid nitrogen and stored at -80 °C. 170 
Sample preparation and fractionation  ? Cell pellets were thawed on ice and re-suspended in 5 ml 171 
cold lysis buffer (20 mM HEPES, 150 mM NaCl, EDTA-free protease inhibitors (Roche), 1mM PMSF, 172 
pH 7.4). For SILAC experiments, equal amount of light and heavy cells were mixed together and 173 
broken in a high pressure cell disrupter (Constant Systems Ltd.) at 35 psi, 4 °C. Lysates were cleared 174 
of cell debris by centrifugation and proteins were denatured by heating and separated by SDS-PAGE. 175 
Polyacrylamide gels were stained with Coomassie InstantBlue and all protein bands were excised 176 
and digested with trypsin as previously described [25]. Briefly, protein bands were excised and 177 
destained by washing with 50 mM ammonium bicarbonate (ABC) and acetonitrile (ACN). Dehydrated 178 
gel bands were soaked in digestion buffer (12.5 ng/µl trypsin in 50 mM ABC) overnight and peptides 179 
extracted by incubating with ACN, 5% formic acid.  180 
LC-MS  ?Samples re-suspended in 0.1% TFA were analysed on an Ultimate 3000 online nano liquid 181 
chromatography system with PepMap300 C18 trapping column (ThermoFisher), coupled to Q 182 
Exactive HF hybrid Quadrupole Orbitrap (ThermoFisher). Peptides were eluted onto a 50 cm x 75 Pm 183 
Easy-spray PepMap C18 analytical column. During analysis the column temperature was maintained 184 
at 40 qC. Peptides were eluted at a flow rate of 300 nL/min using a gradient of 3% to 40% over 60m. 185 
Analytical buffers were composed of 0.1% Formic acid (FA) and either 3% ACN (Buffer A) or 80% ACN 186 
(Buffer B). 0.1% TFA and 3% ACN (Loading buffer). Spray voltage was set to 2.1 kV, S-lens RF level at 187 
60, and heated capillary at 250 °C. MS1 scan resolution was set to 120 000 at m/z 200 and MS2 188 
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resolution was set to 15,000 at m/z 200. Full scan target was 3*106 with a maximum fill time of 100 189 
ms. Mass range was set to 375 - 1500. Target value for fragment scans was set at 5*104, and 190 
intensity threshold was kept at 5*104. Isolation width was set at 1.2. A fixed first mass of 100 was 191 
used. Normalized collision energy was set at 28. Peptide match was set to Preferred, and isotope 192 
exclusion was on. All data was acquired in profile mode using positive polarity. 193 
Data analysis  ? Raw files were processed by MaxQuant v.1.5.2.8 using Andromeda search engine 194 
[26]. All files from a single experiment were processed together and peptide searches were 195 
performed against the Candida albicans protein database SC5314 Assembly 21 downloaded from 196 
candidagenome.org. Arg10 and Lys8 were specified as heavy labels and up to 3 arginine or lysine 197 
labelled amino acids per peptide were allowed. Methionine oxidation and Pro6 were set as variable 198 
modifications and up to 6 per peptide were allowed. Specific digestion with trypsin was chosen with 199 
no more than 2 missed cleavages allowed. Re-quantify was selected to identify missing SILAC pairs. 200 
The peptide tolerance was 4.5 ppm and intensity threshold was set to 500. Peptides were allowed to 201 
be 8-25 amino acids long and up to 4600 Da. False discovery rates (FDR) for peptide spectral 202 
matches (PSM) and proteins was limited to 0.01. Ratios were then corrected using in house 203 
constructed shiny application (Shiny-Pro6Correction) written in R to determine the median isotopic 204 
ratio for evidence peptides lacking proline and comparing it to the median isotopic ratio of evidence 205 
peptides containing a single proline without isotopic labelling [27].  Using this difference ratio as a 206 
correction factor, the observed isotopic ratio of all peptides is corrected based on their proline 207 
content (corrected peptide ratio = peptide ratio*(1+correction factor)*number of prolines in the 208 
peptide). The median corrected isotopic ratio for all evidence peptides within a protein group is then 209 
reported as the corrected protein isotopic ratio with a normalised correction reporting the 210 
adjustment giving a median ratio of 1. Shiny-Pro6Correction is implemented entirely in the R 211 
language. It can be hosted/launched by any system with R installed, including Windows, Mac OS and 212 
most Linux distributions. Information technology administrators can also host Shiny-213 
Pro6Correction from a remote server, in which case users need only have a Web browser installed. 214 
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Shiny-Pro6Correction is provided free of charge under MIT open-source license through GitHub 215 
at https://josephlongworth.github.io/Shiny-Pro6Correction/. Statistical analysis of the data was 216 
done in Perseus, where proteins significantly enriched in either heavy or light isotopes were 217 
identified using the Significance B test based on Benjamini-Hochberg FDR 0.05 [26]. The efficiency of 218 
heavy amino acid incorporation was calculated using the formula: Incorporation = 219 
(H/L)/(H/L+1)×100, where H/L is the normalised ratio of heavy-to-light peptide intensities generated 220 
by the MaxQuant software. Incorporation was calculated for individual peptides first, and then the 221 
average of all peptides. The mass spectrometry data have been deposited to the ProteomeXchange 222 
Consortium via the PRIDE partner repository with the dataset identifier PXD007825 [28].    223 
 224 
 225 
 226 
 227 
 228 
 229 
 230 
 231 
 232 
 233 
 234 
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Results and Discussion 235 
Strain construction and SILAC media formulation.  236 
We constructed a C. albicans strain expressing an inactive phosphatase Cdc14PD that forms stable 237 
interactions with its substrates, but is not able to dephosphorylate them. In the course of 238 
engineering the strain, it was necessary to use the ARG4 gene as a selectable marker, which renders 239 
the cells prototrophic for arginine and auxotrophic for lysine.  The mutation did not affect the 240 
growth rate or the phenotype of C. albicans yeast at least for the duration of SILAC experiments, 241 
indicating that Cdc14 is a haplosufficient allele. Cdc14PD was also able to form true hyphae for at 242 
least 3 hours after promoter induction. Cdc14PD was put under the control of a regulatable MET3 243 
promoter, while the ARG4 gene was controlled by a separate promoter. 244 
 For the purpose of SILAC experiments, Cdc14PD cells were grown in heavy medium (8K10R) 245 
and wild type cells were grown in light medium. In order to keep the growth conditions of both 246 
strains as similar as possible, both media were prepared to be either MET3-inducing or MET3-247 
represing, although wild type cells did not have an ectopic MET3 promoter. The optimal 248 
concentration of lysine was empirically determined to be 0.44 mM. At these concentrations, cells 249 
grew at the same rate in both media (Supplementary figure 1). The same concentration of arginine 250 
was used in media formulation. The results show that neither the mutant allele CDC14PD, nor the 251 
heavy isotope-containing media affected the growth of C. albicans. In addition, alternative media 252 
(including hyphae inducing media) could also be suitable for SILAC, as long as they do not contain 253 
the light versions of amino acids used for labelling. 254 
 255 
Efficiency of SILAC metabolic labelling.  256 
Cdc14PD cells were grown overnight in heavy medium allowing approximately 10 cycles of division. 257 
Soluble protein extracts were prepared and fractionated by SDS-PAGE, and a single fraction was 258 
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analysed by MS to determine the labelling efficiency (see supplementary figures 2 and 3). 63.6% of 259 
the peptides identified contained lysine (but not arginine) with a Lys8 incorporation of 95.43% (see 260 
supplementary figure 3).  Further analysis of the heavy labelling of C. albicans was performed by 261 
examining individual MS spectra of lysine containing peptides (see figure 1). The results show that 262 
the vast majority of peptides displayed a single isotope cluster corresponding to the heavy labelled 263 
peptide. Signals corresponding to the light peptides were not observed or comparable to noise 264 
levels.  265 
Analysis of individual MS spectra of arginine containing peptides show that unlabelled 266 
peptides had significantly lower signal intensities than heavy peptides, typically below 10% (see 267 
figure 2). In addition, the global peptide analysis revealed that the heavy arginine labelling efficiency 268 
was 89.54%. These results demonstrate that C. albicans preferentially use amino acids from the 269 
media even when they are not essential for survival. Although the incorporation efficiency of Arg10 270 
was not as high as that of Lys8, it was sufficient for the purpose of SILAC experiments.  271 
Almost a third of all peptides identified (28.1%) contained arginine but not lysine. If cells 272 
were not labelled with Arg10, these peptides would not be included for protein quantification, 273 
resulting in significant loss of data. Therefore, we achieved a more accurate protein quantification by 274 
using both arginine and lysine incorporation during SILAC labelling. Since two thirds of the peptides 275 
contain lysine rather than arginine, the overall isotope incorporation was 93.87%. Thus, our strategy 276 
of double labelling in lys- arg+ cells will generate improved quantitative mass spectrometry data 277 
compared to using Lys8 only as a single label. Furthermore, these results suggest that C. albicans is a 278 
suitable organism for nSILAC. 279 
 280 
 281 
 282 
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Correction of arginine to proline conversion.  283 
Arginine conversion has been well characterised in S. cerevisiae [29], and this process is 284 
likely to occur in C. albicans, which has orthologues of all enzymes involved in the reaction. Cellular 285 
metabolism of Arg10 may potentially lead to biosynthesis of heavy proline, in particular Pro6 and 286 
additional heavy arginine, namely Arg7. We examined the heavy labelled sample for the presence of 287 
Pro6 and Arg7 and found that proline conversion occurred at a rate of 18.9% (see supplementary 288 
figure 4), but Arg7 was not detected.  Arginine to proline conversion was also analysed by examining 289 
individual MS spectra of proline containing peptides (see figure 3A/B). The results clearly 290 
demonstrate the additional isotope clusters present in the spectra of proline containing peptides 291 
due to the incorporation of heavy proline. The incorporation of heavy proline will result in an 292 
underestimation of the heavy:light ratio using automated software analysis such as MaxQuant. 293 
Therefore, we developed a computational method to correct for the heavy arginine to proline 294 
conversion by measuring the change in observed peptide evidence isotopic ratio, stratified by 295 
proline content. The heavy isotope underestimation was determined based on the peptides 296 
containing a single proline residue. Peptides with one potential conversion provide the superior 297 
measurement of the error observed given their greater abundance. This correction factor could then 298 
be applied to all proline-containing peptides based on their respective proline content.  299 
The isotopic ratio distribution for peptides depending on their proline content is shown in 300 
figure 3C/D pre and post correction. Peptides were sorted according to the number of proline 301 
residues comparing the median H/L ratio. Peptides containing a single proline were determined to 302 
have a 35.7% lower H/L ratio than peptides with no prolines (see figure 3C). Therefore, a correction 303 
factor of 0.357 per proline was applied to the affected peptides. After correction, peptide ratios 304 
were normalised so that the median H/L ratio was adjusted to 1. Peptides in all groups displayed 305 
similar H/L ratios regardless of their proline count (see figure 3C). The alignment of the distributions 306 
post correction indicate the true differential in the experiment. It should be noted that whilst Pro6 307 
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containing peptides were not utilised in the determination of protein quantifications, they were 308 
included in the original search as their observations are valid to support protein identifications. 309 
In order to test if our method correctly amends the isotope ratios, as a positive control we 310 
mixed wild type cells grown in heavy and light SILAC medium in a 1:1 ratio prior to LC MS analysis. 311 
Samples were prepared and analysed as previously described (see supplementary figure 5A). The 312 
results show that only those peptides with no prolines had a median H/L peptide ratio of 1. In 313 
contrast, proline-containing peptides had a significantly lower H/L ratio, which decreased 314 
proportionally with the number of proline residues (see supplementary figure 5A). After applying the 315 
Shiny-Pro6 correction, all H/L peptide ratios were similar and close to 1, demonstrating that the 316 
Shiny-Pro6 method corrects the H/L peptide ratio errors caused by the arginine-to-proline 317 
conversion. 318 
We further compared our peptide ratio normalisation method to the MaxQuant 319 
normalisation method. The H/L peptide ratios (not corrected for Pro6 and not normalised by 320 
MaxQuant) were normalised by both Shiny-Pro6 and MaxQuant (see supplementary figure 5B). The 321 
results show the excellent correlation between the different normalisation methods, further 322 
demonstrating that Shiny-Pro6 correctly normalises the H/L ratios after correcting for arginine to 323 
proline conversion.  324 
 325 
Quantitative proteomic analysis of Cdc14PD overexpression in C. albicans. 326 
Following the demonstration of the SILAC labelling of C. albicans proteome with heavy 327 
amino acids (arginine and lysine) and the development of computational methods to correct for the 328 
proline conversion, we performed a proof of principle application of SILAC labelling of C. albicans  329 
and measured the global proteomic changes that occur in response to overexpressing the inactive 330 
phosphatase Cdc14PD. Cdc14PD cells were grown in the presence of Lys8 and Arg10, while wild type 331 
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cells were grown in media containing only light amino acids. Both strains were grown in heavy 332 
MET3-repressing media overnight, and then in heavy MET3-inducing media for 4 hours. Thus, 333 
Cdc14PD was overexpressed for only 4 hours. Wild type cells were grown in light media in the same 334 
conditions. Cells from both strain were harvested and mixed together prior to cell lysis, protein 335 
extraction and GeLC MS analysis. The results are summarised in supplementary Table 1 and Figure 4.  336 
Proteome analysis of C. albicans overexpressing an inactive phosphatase Cdc14PD resulted in 337 
the identification of 2541 proteins representing 40.1% of the cellular proteome, with 2339 proteins 338 
quantified (see supplemental tables 1 and 2). The quantitative SILAC MS analysis revealed that 103 339 
proteins were significantly upregulated (see supplementary table 3), while 28 proteins were 340 
significantly downregulated in Cdc14PD compared to the wild type proteome (see figure 4). A gene 341 
ontology (GO) analysis of the 131 differentially expressed proteins revealed that almost a third 342 
(29.8%) are involved in oxidation-reduction processes and 12.2% take part in monocarboxilic acid 343 
metabolic processes (see supplementary figure 6 and supplementary table 4). Oxidoreductases play 344 
an important role in regulating CDC14B in mammalian cells, where the phosphatase activity is 345 
inhibited by high intracellular concentrations of H2O2 [30].Therefore, such changes in the proteome 346 
may reflect the  presence of Cdc14PD above physiological levels as well as the different amino acid 347 
requirements of the mutant strain compared to the wild type strain. Further experiments should be 348 
performed to elucidate the relationship between Cdc14 and the proteins presented here and further 349 
analyse the interacting partners of Cdc14 in C. albicans. 350 
 351 
 352 
 353 
 354 
 355 
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Conclusions 356 
In this study we have for the first time developed and utilised SILAC-MS workflows for 357 
quantitative proteomics in the fungal pathogen Candida albicans. The fungus Candida albicans is 358 
commonly found on the skin and mucosal surfaces of healthy people, but in susceptible individuals, 359 
it causes infections ranging from superficial to life threatening. In C. albicans, arginine is commonly 360 
used as a selectable marker in strain engineering. Arginine metabolism provides important cues for 361 
escaping host defences during pathogenesis, which limits the use of auxotrophs in Candida research. 362 
In this study we have utilised a strategy that eliminates the need for engineering arginine auxotrophs 363 
for SILAC experiments and allows the use of ARG4 as selectable marker during strain construction in 364 
Candida albicans. This opens up new possibilities for studying protein interactions, post-translational 365 
modifications and whole proteome changes in response to different factors that occur during the 366 
lifecycle of this fungus. 367 
We have developed and used nSILAC in C. albicans, although cells were able to synthesise 368 
arginine internally, we were able to achieve approximately 90% heavy arginine incorporation, which 369 
was slightly lower than that of the essential amino acid lysine. Previously, nSILAC has been applied in 370 
ďĂŬĞƌ ?Ɛ ĂŶĚ ďƵĚĚŝŶg yeast using heavy lysine [4]. A protein turnover study done in S. cerevisiae 371 
showed that the proteome was almost fully labelled in actively growing cells, but cells resumed 372 
lysine biosynthesis in stationary phase [5]. In our experiments, cells were grown in heavy medium 373 
overnight, when they inevitably reached stationary phase several hours before being re-inoculated 374 
into fresh medium. Thus, it is likely that cells were feeding on supplemental heavy arginine in the 375 
exponential phase, and switched to production of light arginine in stationary phase. Cells were then 376 
allowed to re-enter exponential growth for 4 hours, and likely downregulate the rate of endogenous 377 
arginine production. It is proposed that the efficiency of arginine incorporation could be improved 378 
by harvesting the cells before they reached stationary phase of growth. 379 
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Catabolic conversion of arginine to proline is a well-known problem in SILAC experiments 380 
using heavy arginine as a label. In C. albicans, almost a fifth of all proline residues were synthesised 381 
using Arg10 as a precursor. This metabolic conversion can be prevented by titrating concentrations 382 
of both arginine and proline in the media. However, this is difficult to achieve in prototrophic 383 
organisms because cells need sufficient amount of heavy arginine in order to shut down endogenous 384 
production. Engineering an arginase-deficient strain is also possible, but not practical in C. albicans 385 
as previously described. Therefore, we developed a computational method to correct the protein 386 
SILAC (H/L) ratios, which normalises the ratios of proline-containing peptides to those of proline-free 387 
peptides. We performed a proof of principle application of SILAC labelling of C. albicans and 388 
measured the global proteomic changes that occur in response to overexpressing the inactive 389 
phosphatase Cdc14PD. The analysis resulted in the quantification of 2339 proteins of which 131 390 
proteins were significantly up/down regulated compared to the wild type cells. 391 
 392 
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Figure Legends: 424 
 425 
Fig. 1: ESI-MS of 8K-labelled peptides. Analysis of the MS spectra of the tryptic peptides A) 426 
LYGGAAGEGAGGAGDAK and B) MKETAEGFLGTTVK from cells grown on heavy SILAC (8K10R) labelled 427 
media reveals no significant signal corresponding to the 0K peptide consistent with the high average 428 
incorporation efficiency (95.43%) determined from the global analysis of heavy lysine peptides. Blue 429 
and red squares show the position of light (0K) and heavy (8K) peptides respectively. 430 
 431 
Fig. 2: Incorporation of 10R in prototrophic C. albicans. Analysis of the MS spectra of the tryptic 432 
peptides A) VEIIANDQGNR and B) VDEIVLVGGSTR from cells grown on heavy SILAC (8K10R) labelled 433 
media reveals a small signal corresponding to the 0R peptide in each case consistent with the lower 434 
average incorporation efficiency of heavy arginine (89.54%) determined from the global peptides 435 
analysis of heavy arginine peptides.   Blue and red squares show the position of light (0R) and heavy 436 
(10R) peptides respectively. 437 
 438 
Fig. 3: Arginine to proline conversion. MS spectra of the tryptic proline-containing peptides A) 439 
GPLVVYAQDNGIVK and B) GHDIPHPITTFDEAGFPDYVLQEVK from Candida cells grown on heavy 440 
(8K10R) and light (0K0R)  SILAC media mixed in a 1:1 ratio. Blue squares show the position of light (0K) 441 
peptides and red squares show the position of the heavy isotope clusters from the (8K/6P8K) peptides 442 
respectively. C)  Scatter plots of the peptides H/L ratio versus proline content before and after 443 
correction. D) A box plot showing a global protein analysis of the H/L ratios before and after 444 
correction for heavy arginine to proline conversion. 445 
 446 
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Fig. 4: Quantitative proteomic analysis in C. albicans using SILAC.  A) Plot of protein intensities 447 
against normalized H/L SILAC ratios of WT C. albicans cells grown in light (0K0R) media and Cdc14PD C. 448 
albicans cells grown heavy (8K10R) SILAC media. Significant outliers were determined using the 449 
Significance B test and are coloured in blue (FDR < 0.05); other proteins are shown in grey. B) 450 
Histogram showing the normalised heavy to light protein ratio distributions. The frequency 451 
represents the number of proteins in each bin. 452 
 453 
 454 
 455 
 456 
 457 
 458 
 459 
 460 
 461 
 462 
 463 
 464 
 465 
 466 
 467 
21 
 
References 468 
[1] Bantscheff, M., Schirle, M., Sweetman, G., Rick, J., Kuster, B., Analytical and bioanalytical 469 
chemistry 2007, 389, 1017-1031. 470 
[2] Zhang, G., Fenyo, D., Neubert, T. A., Journal of proteome research 2009, 8, 1285-1292. 471 
[3] Chen, X., Wei, S., Ji, Y., Guo, X., Yang, F., Proteomics 2015, 15, 3175-3192. 472 
[4] Frohlich, F., Christiano, R., Walther, T. C., Mol Cell Proteomics 2013, 12, 1995-2005. 473 
[5] Martin-Perez, M., Villen, J., Analytical chemistry 2015, 87, 4008-4014. 474 
[6] Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., Mann, M., Mol 475 
Cell Proteomics 2002, 1, 376-386. 476 
[7] Gruhler, A., Olsen, J. V., Mohammed, S., Mortensen, P., Færgeman, N. J., Mann, M., Jensen, O. N., 477 
Mol Cell Proteomics 2005, 4, 310-327. 478 
[8] Lossner, C., Warnken, U., Pscherer, A., Schnolzer, M., Analytical biochemistry 2011, 412, 123-125. 479 
[9] Blagoev, B., Mann, M., Methods (San Diego, Calif 2006, 40, 243-250. 480 
[10] Schmidt, F., Strozynski, M., Salus, S. S., Nilsen, H., Thiede, B., Rapid Commun Mass Spectrom 481 
2007, 21, 3919-3926. 482 
[11] Bendall, S. C., Hughes, C., Stewart, M. H., Doble, B., Bhatia, M., Lajoie, G. A., Mol Cell Proteomics 483 
2008, 7, 1587-1597. 484 
[12] Bicho, C. C., de Lima Alves, F., Chen, Z. A., Rappsilber, J., Sawin, K. E., Mol Cell Proteomics 2010, 485 
9, 1567-1577. 486 
[13] Borek, W. E., Zou, J., Rappsilber, J., Sawin, K. E., PloS one 2015, 10, e0129548. 487 
[14] Van Hoof, D., Pinkse, M. W., Oostwaard, D. W., Mummery, C. L., Heck, A. J., Krijgsveld, J., Nature 488 
methods 2007, 4, 677-678. 489 
[15] Park, S. K., Liao, L., Kim, J. Y., Yates, J. R., 3rd, Nature methods 2009, 6, 184-185. 490 
[16] van Breukelen, B., van den Toorn, H. W., Drugan, M. M., Heck, A. J., Bioinformatics (Oxford, 491 
England) 2009, 25, 1472-1473. 492 
[17] Pasculescu, A., Schoof, E. M., Creixell, P., Zheng, Y., Olhovsky, M., Tian, R., So, J., Vanderlaan, R. 493 
D., Pawson, T., Linding, R., Colwill, K., Journal of proteomics 2014, 100, 167-173. 494 
[18] Kibbler, C. C., Seaton, S., Barnes, R. A., Gransden, W. R., Holliman, R. E., Johnson, E. M., Perry, J. 495 
D., Sullivan, D. J., Wilson, J. A., The Journal of hospital infection 2003, 54, 18-24. 496 
[19] Nobile, C. J., Johnson, A. D., Annual review of microbiology 2015, 69, 71-92. 497 
[20] Schaller, M., Borelli, C., Korting, H. C., Hube, B., Mycoses 2005, 48, 365-377. 498 
[21] Lorenz, M. C., Bender, J. A., Fink, G. R., Eukaryotic cell 2004, 3, 1076-1087. 499 
[22] Ghosh, S., Navarathna, D. H., Roberts, D. D., Cooper, J. T., Atkin, A. L., Petro, T. M., Nickerson, K. 500 
W., Infection and immunity 2009, 77, 1596-1605. 501 
[23] Lavoie, H., Sellam, A., Askew, C., Nantel, A., Whiteway, M., BMC genomics 2008, 9, 578. 502 
[24] Gola, S., Martin, R., Walther, A., Dunkler, A., Wendland, J., Yeast (Chichester, England) 2003, 20, 503 
1339-1347. 504 
[25] Pandey, A., Andersen, J. S., Mann, M., Sci STKE 2000, 2000, pl1. 505 
[26] Cox, J., Mann, M., Nature biotechnology 2008, 26, 1367-1372. 506 
[27] Chang, W., Cheng, J., Allaire, J. J., Xie, Y., McPherson, J., 2017. 507 
[28] Vizcaino, J. A., Csordas, A., Del-Toro, N., Dianes, J. A., Griss, J., Lavidas, I., Mayer, G., Perez-508 
Riverol, Y., Reisinger, F., Ternent, T., Xu, Q. W., Wang, R., Hermjakob, H., Nucleic acids research 2016, 509 
44, 11033. 510 
[29] Ong, S. E., Kratchmarova, I., Mann, M., Journal of proteome research 2003, 2, 173-181. 511 
[30] Lim, J. M., Lee, K. S., Woo, H. A., Kang, D., Rhee, S. G., The Journal of cell biology 2015, 210, 23-512 
33. 513 
 514 
 515 
